Delivery Order SPE2DB22D1017-SPE2DB25FF9BC
Award Date
4/1/25
Potential Completion Date
4/2/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $6,464.28 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Bydureon BCISE 2 mg autoinjector medical devices, which are used for the treatment of diabetes. The contract has a performance period through February 26, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a $1,570.20 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. This delivery order is issued under a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a...
This is a $8,636.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used in the treatment of type 2 diabetes. The contract has an ultimate completion date of March 13, 2025 and was awarded on March 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a $2,199.76 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used for diabetes management. The contract has a period of performance through February 18, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, acting as a primary...
This is a $16,626.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of Bydureon Bcise 2 mg autoinjectors, which are used to treat type 2 diabetes. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a $8,269.83 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of June 28, 2024 and was awarded on June 27, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Bydureon Bcise 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has a ceiling value of $7,900.38 and a completion date of March 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a $4,997.70 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product, with a period of performance through April 30, 2024. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a $5,260.74 Firm Fixed Price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a specialty medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has a ceiling value of $3,240.42 and an ultimate completion date of March 31, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...